We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Information for health professionals on the characteristics, diagnosis and treatment of Pontiac fever.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
Employment Appeal Tribunal judgment of Judge Tayler on 09 July 2024.
The symptoms, diagnosis, management, surveillance and epidemiology of Legionnaires' disease.
Explains how commissioners and health professionals can use data and analysis for decisions about neurology services and interventions.
The epidemiology, symptoms, diagnosis and management of monkeypox virus infections.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).